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Abstract
We introduce alevin, a fast end-to-end pipeline to process droplet-based single-cell RNA sequencing data,
performing cell barcode detection, read mapping, unique molecular identifier (UMI) deduplication, gene count
estimation, and cell barcode whitelisting. Alevin’s approach to UMI deduplication considers transcript-level
constraints on the molecules from which UMIs may have arisen and accounts for both gene-unique reads and reads
that multimap between genes. This addresses the inherent bias in existing tools which discard gene-ambiguous reads
and improves the accuracy of gene abundance estimates. Alevin is considerably faster, typically eight times, than
existing gene quantification approaches, while also using less memory.
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Background
There has been a steady increase in the throughput
of single-cell RNA-seq (scRNA-seq) experiments, with
droplet-based protocols (dscRNA-seq) [1–3] facilitating
experiments assaying tens of thousands of cells in paral-
lel. The three most widely used dscRNA-seq protocols:
Drop-seq [1], inDrop [2], and 10X Chromium [3], use two
separate barcodes that require appropriate processing for
accurate quantification estimation. First, cellular barcodes
(CBs) are used to tag each cell with a unique barcode,
which enables pooling of cells for sequencing and their
subsequent separation in silico. Thus, data processing
requires the identification of the true CBs corresponding
to distinct cells, and grouping the reads accordingly. Sec-
ond, identification of PCR duplicates is aided by unique
molecular identifiers (UMIs), which tag each unique
molecule prior to amplification. Since the mRNA capture
rate is only around 5–10% [4], many rounds of PCR are
typically performed prior to sequencing [1]. Appropriately
accounting for the barcode information is therefore cru-
cial for accurate estimation of gene expression. Only a
minor fraction of the possible CBs present will ultimately
tag a cell, and likewise, only a minor fraction of UMIs will
tag unique molecules from the same gene. Thus, in each
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case, the aim is to identify the barcodes used. Unfortu-
nately, both CBs and UMIs are subject to errors that occur
during sequencing and amplification [1, 5], which makes
the accurate deconvolution of this information in silico a
non-trivial task. This task is made more difficult by the
amplification of background RNA from empty droplets
(ambient CBs) or damaged cells.
Various methods have been proposed to correctly pro-
cess dscRNA-seq barcodes in an error-aware manner
(“whitelisting”) [3, 5–8], to correct sequencing errors
in CBs and UMIs [5, 8], to deduplicate UMI tags
inferred to be duplicates [5], and to obtain cell-level gene
quantification estimates [9]. Here, we describe an end-
to-end quantification pipeline that takes as input sample-
demultiplexed FASTQ files and outputs gene-level UMI
counts for each cell in the library. We call this unified
pipeline alevin, and it overcomes two main shortcomings
of traditional pipelines. First, existing techniques for UMI
deduplication discard reads that map to more than one
gene. In bulk RNA-seq datasets (with paired-end reads
and full-length transcript coverage), the proportion of
gene-ambiguous reads is generally small (Table 1). Yet, in
tagged-end scRNA-seq, this set of gene-ambiguous reads
is generally larger and commonly accounts for ∼ 14–
23% of the input data (Table 2). This is a result of both
the fact that dscRNA-seq protocols, by construction, dis-
play a very strong 3′ bias and that these protocols yield
effectively single-end reads (only one of the sequenced
© The Author(s). 2019 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Srivastava et al. Genome Biology           (2019) 20:65 Page 2 of 16
Table 1 The percentage of reads multimapping in bulk datasets
from human and mouse
Species Accession number Read length Percentage
Human SRR1303990 [32] 101 7.4
Human SRR1373442 [33] 49 9.2
Human SRR1644186 [34] 100 9.2
Human SRR5074291 [35] 150 7.7
Mouse ERR435943 [36] 75 23
Mouse SRR3532922 [37] 125 10.6
Mouse SRR6753775 [38] 150 5.6
Mouse SRR327047 [22] 120 5.2
We use these datasets for various analyses throughout themanuscript. Note that this
percentage varies depending on the read length as well as the overall quality of the
dataset
reads contains sequence from the underlying transcript),
resulting in a reduced ability to resolve multimapping
using a pair of reads from a longer fragment. We show
that discarding the multimapping reads can negatively
bias the gene-level counts predicted by various methods.
Second, existing quantification pipelines combine inde-
pendent processing algorithms and tools for each step,
usually communicating results between pipeline stages via
intermediate files on disk, which significantly increases
the processing time and memory requirements for the
complete analysis. We show that alevin makes use of more
reads than other pipelines, that this leads tomore accurate
quantification of genes, and that alevin does this∼8 times
faster and with a lower memory requirement, when com-
pared to existing best practice pipelines for dscRNA-seq
analysis.
Results
Alevin overview
There are several steps in the alevin pipeline that are
streamlined to work without the overhead of writing to
disk, as highlighted in Fig. 1 (details in the “Materi-
als and methods” section). The first step is to identify
the CBs that represent properly captured and tagged
cells (“whitelisting”). Alevin uses a two-step whitelist-
ing procedure, where the second step takes place at the
end of the pipeline. An initial whitelist is produced by
Table 2 Percentage of reads multimapping across various
scRNA-seq samples, using the alevin mappings
Sample Percentage
Human PBMC 4k 14.2
Human PBMC 8k 14.1
Mouse neurons 900 21.8
Mouse neurons 2k 22.7
Mouse neurons 9k 17.2
finding the “knee” in the cumulative distribution of CB
frequencies [1, 3]. For each non-whitelisted CB, alevin
tries to correct it to a whitelisted CB either by a substitu-
tion or by a single insertion or deletion. If no such barcode
exists in the set of whitelisted barcodes, the barcode and
its associated reads are discarded. The next step is map-
ping reads from the whitelisted CBs, and the corrected
CBs, to a target transcriptome [10, 11], followed by UMI
deduplication.
The process of deduplication requires identifying dupli-
cate reads based on their UMIs and alignment positions
along the transcriptome. Alevin uses a novel algorithm for
deduplication that begins by constructing parsimonious
UMI graphs, that we refer to as a PUGs, using infor-
mation from the UMI sequences, the UMI counts, and
the transcript equivalence classes [12]. This PUG is con-
structed such that each UMI-transcript equivalence class
pair is represented by a node and there exists an edge
from a node to any node that could have arisen from
an amplified molecule due to sampling the underlying
transcript (a single pre-PCR molecule) at a different posi-
tion, or via a PCR or a sequencing error being introduced
into the UMI. When the direction of “duplication” during
PCR is clear, a directed edge is added; otherwise, a bi-
directed edge is placed. An optimal covering of this graph,
using the transcripts associated with each node, will give
the minimum number of UMIs, along with their counts,
required to explain the set of mapped reads. Hence, we
have mapped the deduplication problem to that of find-
ing a minimum cardinality covering of a given graph by
monochromatic arborescences. Since the decision version
of this problem is NP-complete, we propose a greedy algo-
rithm to obtain a minimum cardinality covering of this
graph (proof and algorithm detailed under the “Materials
and methods” section). Each covering, and the associated
UMI, is assigned a set of transcript labels of size ≥ 1.
After this UMI resolution phase, the remaining ambigu-
ous reads with more than 1 transcript label are assigned
based on an expectation-maximization method [13].
Finally, having obtained per-cell gene expression esti-
mates, CB whitelisting is finalized using a naïve Bayes
classifier to differentiate between high- and low-quality
cells utilizing a set of features derived from the expression
estimates and other diagnostic features [8]. In addition to
the gene-by-cell count matrix, alevin also provides infor-
mation about the reliability of the abundance estimate
computed for each gene in each cell in the form of a tier
matrix (and, optionally, the summarized variance of boot-
strap estimates), which succinctly encodes the quality of
the evidence used to derive the corresponding count.
Impact of discarding multimapping reads
Before proceeding with a more detailed analysis of the
alevin pipeline, it is important to highlight scenarios
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Fig. 1 Overview of the alevin pipeline. The input to the pipeline are sample-demultiplexed FASTQ files, and there are several steps, outlined here,
that are required to process this data and obtain per-cell gene-level quantification estimates. The first step is cell barcode (CB) whitelisting using
their frequencies. Barcodes neighboring whitelisted barcodes are then associated with (collapsed into) their whitelisted counterparts. Reads from
whitelisted CBs are mapped to the transcriptome, and the UMI-transcript equivalence classes are generated. Each equivalence class contains a set of
transcripts, the UMIs that are associated with the reads that map to each class and the read count for each UMI. This information is used to construct
a parsimonious UMI graph (PUG) where each node represents a UMI-transcript equivalence class and nodes are connected based on the associated
read counts. The UMI deduplication algorithm then attempts to find a minimal set of transcripts that cover the graph (where each consistently
labeled connected component—each monochromatic arborescence—is associated with a distinct pre-PCR molecule). In this way, each node is
assigned a transcript label and, in turn, an associated gene label. Reads associated with arborescences that could be consistently labeled by multiple
genes are divided amongst these possible loci probabilistically based on an expectation-maximization algorithm. Finally, optionally, and if not
provided with high-quality CB whitelist externally, an intelligent whitelisting procedure finalizes a list of high-quality CBs using a naïve Bayes
classifier to differentiate between high- and low-quality cells
where existing pipelines would fail using simple exam-
ples. These also lead to a better understanding of the
alevin UMI deduplication algorithm that intelligently
utilizes transcript-level information to obtain accu-
rate gene-level estimates. Since current deduplication
methods do not have a mechanism to detect UMIs
that map between multiple transcripts of the same
gene, they can, in certain cases, incorrectly detect PCR
duplicates and, hence, under-estimate the total UMI
counts. Some obvious cases can be resolved by
considering the read-to-transcript mapping, instead of
the read-to-gene mapping, as done in alevin and shown
in the left panel in Fig. 2. The first row (top to bottom)
demonstrates a case when we observe the same UMI (U1)
being used to tag transcripts from two separate genes
(G1 and G2). Here, all methods are able to correctly
assess that these instances of U1 are not PCR duplicates.
In the center row, we observe the same UMI deriving
from two (sequence-distinct) transcripts of the same
gene. Here, purely gene-level methods fail to resolve
this collision, while alevin’s strategy can. Finally, in the
bottom row, we observe a UMI collision within a single
transcript. That is, two different copies (molecules) of
the same transcript have been tagged with the same
UMI. This cannot be resolved by any of the methods.
Though possible, the situation presented in the third row
is highly unlikely, especially given the current sequencing
depths.
Srivastava et al. Genome Biology           (2019) 20:65 Page 4 of 16
(a) (b)
Fig. 2 a This figure illustrates examples of various classes of UMI collisions and which method(s) would be able to correctly resolve the origin of the
multimapping reads in each scenario. These cases are shown top to bottom in order of their likelihood. b A simulated example demonstrates how
treating equivalence classes individually during UMI deduplication can lead to under-collapsing of UMIs compared to gene-level methods
(especially in protocols where the majority of cDNA amplification occurs prior to fragmentation). In the first row, both methods report correctly two
UMIs. In the second row, there are two fragmented molecules aligned against two transcripts from the same gene. The alevin deduplication
algorithm will attempt to choose the minimum number of transcripts required to explain the read mappings and hence correctly detect the UMI
counts. The equivalence class method will over-estimate the gene count
A second scenario is highlighted in the right panel
of Fig. 2 where using the transcript-level equivalence
classes lead to over-counting UMIs (discussed further in
the “Materials and methods” section). In these simulated
examples, different types of transcripts and correspond-
ing expression patterns are shown. Reads are randomly
sampled from the 3′-end of the annotated transcript(s)
according to a realistic fragment length distribution,
where exon overlap induces the corresponding equiva-
lence classes of each fragment. The top simulation shows
1 (pre-PCR) molecule expressed for each transcript, iden-
tifiable by a unique id (UMI), shown in blue. Due to the
disjoint equivalence classes, both methods will correctly
assign the gene count. In the bottom simulation, both
molecules originate from the second transcript. However,
since the equivalence classes are different, the two frag-
ments sharing a UMI will not be collapsed. Specifically,
as the rate of splicing (and hence the number of equiva-
lence classes) increases, so too does the number of distinct
UMIs reported. In this case, the alevin UMI deduplication
algorithm will correctly detect the number of transcripts
in order to greedily assign the minimum number of tran-
scripts required to explain the given UMI and mapping
information.
To show that the UMI deduplication algorithm from
alevin does, indeed, perform better, we calculate the ratio
of the number of reads mapping to each gene and the
final count of UMIs as predicted by alevin and Cell Ranger
for that gene. When a read maps ambiguously, the count
is divided uniformly between the genes. Hence, if a read
maps to two genes, the count for each is incremented by
0.5 to get the initial number of reads mapping to these
genes. Note that the mappings are also different under
each pipeline and that some reads may be inherently
ambiguous under one or both mappings. These reads can-
not be accurately assigned but, while Cell Ranger discards
them, alevin assigns them to a gene via the PUG reso-
lution algorithm, or, in the case that parsimony fails to
distinguish a single best gene, proportionally to multiple
genes according to the other uniquely mapping reads of
the experiment.We divide the genes into 20 bins, based on
the number of k-mers shared across genes. We expect the
above calculated ratio to remain fairly consistent across
these 20 bins, irrespective of the sequence properties of
the genes in them. However, we observe in Fig. 3 that the
predictions from Cell Ranger are biased for the genes with
low sequence uniqueness. This is because a large num-
ber of reads from these genes will multimap across genes
and will, therefore, be discarded. Hence, simply discard-
ing multimapping reads seems to bias the count estimates
for all genes but strongly impacts counts for genes that are
expected to have a larger number of multimapping reads
due to their high sequence similarity.
Accuracy analysis on real datasets
To assess the performance of alevin, both in terms of accu-
racy in quantification and resource consumption, we ran it
on 10X Chromium datasets from human and mouse. We
compare our results against the Cell Ranger pipeline [3],
the dropEst pipeline [8]1, and a custom pipeline, with an
external list of whitelisted CBs, using STAR [14], feature-
Counts [15], and UMI-tools [5], which we refer to as the
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Fig. 3 The ratio of the final number of deduplicated UMIs against the number of initial reads for both alevin and Cell Ranger (on the human PBMC
4k dataset) stratified by gene-level sequence uniqueness. The genes are divided into 20 equal sized bins, and the x-axis represents the maximum
gene uniqueness in each bin. The plotted ratio for genes that have high sequence similarity with other genes is strongly biased when using
Cell Ranger. This is because Cell Ranger will discard a majority (or all) of the reads originating from these genes since they will most likely map to
multiple positions across various genes. Alevin, on the other hand, will attempt to accurately assign these reads to their gene of origin. This plot also
demonstrates that alevin does not over-count UMIs, which would be the case if deduplication was done at the level of equivalence classes
naïve pipeline. The exact parameters for running each tool
are provided under the “Materials and methods” section.
Note that we run alevin with the --keepDuplicates
flag during indexing, which ensures that even whenmulti-
ple sequence-identical transcripts exist in the annotation,
they are not discarded. This is to allow for fair compar-
ison against the other tools, since they do not discard
such transcripts, and the existence of such transcripts
will impact the number of multimapping reads. How-
ever, we do not generally recommended using this flag
when running alevin. We observe that the number of final
whitelisted cells predicted by alevin are in close proxim-
ity to the count of cells predicted by Cell Ranger (and
dropEst, since they use the same whitelist), but there
are non-trivial differences (Table 3). Comparison on data
using the Drop-seq [1] protocol is also detailed below.
Comparisons against the recently released version 3.0.0
of Cell Ranger are also provided (Additional file 1: Figure
S1), along with results from another run of alevin using
different parameters. Where mentioned, the results are
stratified by gene uniqueness which is the proportion of k-
mers, of size 31, that are not shared between two or more
genes. We note that varying the k-mer size changes the
stratification of the genes but does not impact the over-
all correlation and performance of the methods. We show
this for the mouse neuronal 900 dataset (Additional file 1:
Figure S2). We calculated this for each gene in the human
(GENCODE release 27, GRCh38.p10) and mouse (GEN-
CODE release M16, GRCm38.p5) transcriptomes. Note
that this was not calculated using the canonicalized k-
mers from the genes. This is because the scRNA-seq
protocols are stranded and a read, therefore, cannot mul-
timap between two genes if the reverse complement of one
of them is shared with the other’s forward sequence.
Accuracy of estimates against bulk data
To test the accuracy of the quantification estimates, we
aggregate the estimates from each of the single-cell quan-
tification tools (summing across all cells) and calculate
the correlation with estimates predicted by RSEM [16]
(paired with Bowtie2 [17] alignments) using bulk datasets
Table 3 Number of final whitelisted cellular barcodes output by
alevin and Cell Ranger
Dataset Cell Ranger Alevin No. of reads
Human PBMC 4k 4346 4341 379,462,522
Human PBMC 8k 8379 8291 784,064,148
Mouse neurons 900 933 1291 52,805,264
Mouse neurons 2k 2009 1881 147,010,995
Mouse neurons 9k 9116 8519 383,366,284
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from the same cell types. While the differences between
single-cell and bulk sequencing protocols and techniques
are significant, we believe that, in the absence of estab-
lished benchmarks, the correlation between them is a
reasonable indicator of the accuracy of each quantifi-
cation method. Estimates from alevin, when summed
across all cells, have a higher Spearman rank correla-
tion than the Cell Ranger, dropEst, and naïve pipelines
(Table 4). Specifically, we posit that the methods demon-
strate a strong and persistent bias against groups of
two or more genes that exhibit high sequence similarity.
That is, the more sequence-similar a gene is to another
gene, the less likely these pipelines are able to assign
reads to it—in the extreme case, some genes essentially
become invisible due to the in silico biases of these
approaches (a similar effect was reported by Robert and
Watson [18] in bulk RNA-seq data when simple read-
counting approaches are used for quantification, where
they highlight that many such genes are relevant to human
disease).
To further explore this hypothesis, we stratified the
accuracy of the different methods by the uniqueness of
the underlying genes (Fig. 4a, Table 5). The bar plots
at the top of each subfigure represent the tiers of the
genes as assigned by alevin. Tier 1 is the set of genes
where all the reads are uniquely mapping. Tier 2 is
genes that have ambiguously mapping reads, but con-
nected to unique read evidence as well, which can be
used by the EM to resolve the multimapping reads.
Tier 3 is the genes that have no unique evidence, and
the read counts are, therefore, distributed between these
genes according to an uninformative prior. In agree-
ment with the hypothesized relationship, we observed
that the higher accuracy of alevin is particularly large for
genes with a lower proportion of unique k-mers, which
tend to belong to tier 2 or 3. On genes from tier 1,
all the methods perform similarly. Thus, the approach
of Cell Ranger, dropEst, and naïve, which discard reads
mapping to multiple genes, results in systematic inaccu-
racies in genes which are insufficiently unique (i.e., which
share a high degree of sequence homology with some
other gene).
Table 4 Average Spearman correlation of gene-level estimates
from each method for the single-cell datasets against bulk data
from the same cell types (four for human, three for mouse)
Dataset Alevin Cell Ranger Naïve DropEst
Human PBMC 4k 0.813 0.78 0.747 0.783
Human PBMC 8k 0.81 0.772 0.74 0.776
Mouse neurons 900 0.812 0.773 0.761 0.779
Mouse neurons 2k 0.822 0.781 0.767 0.784
Mouse neurons 9k 0.831 0.796 0.776 0.803
This bias could impact the expression estimates of
important marker genes, such as the genes for the
hemoglobin alpha and beta proteins in the mouse neurons
[19, 20]. Due to their lower uniqueness ratio, Cell Ranger
appears to exhibit a bias against such genes, and their
expression, as predicted by alevin, is systematically higher
(Fig. 5). Anecdotally, we also noticed that, in the human
PBMC data, alevin sometimes predicts the expression of
even relatively sequence-unique genes, like YIPF6, that we
expect to be expressed in a subpopulation of these cells
(monocytes) [21], but which exhibit almost no expres-
sion as predicted by Cell Ranger (Fig. 6). Because the
bias against sequence-ambiguous genes is fundamental
and sequence-specific, it cannot be easily remedied with
more data, but instead requires the development of fun-
damentally novel algorithms, like alevin, that account for,
rather than discard, reads mapping to such genes. Hence,
alevin not only quantifies a greater proportion of the
sequenced data than existing methods, but also does so
more accurately and in a less biased manner.
Accuracy of estimates using combined genomes
To further assess the accuracy of quantification esti-
mates, in the absence of any established read-level sim-
ulation protocol, we performed an experiment aimed
to introduce controlled gene-level multimapping to ana-
lyze its effect on the different methods. We quantified
the mouse neuronal 900 sequencing dataset using both
Cell Ranger and alevin, and each quantification was per-
formed under two separate references: the mouse genome
and the combined human and mouse genome. Not-
ing that the reads in this experiment originate from
mouse, we desire that the quantifications returned by
a method deviate as little as possible under the two
different reference configurations. Under ideal condi-
tions, for example, the gene counts under both references
should be the same. However, combining the mouse and
human references increases the gene sequence ambigu-
ity, due to the presence of homologous genes, resulting in
misestimation.
We show in Fig. 7a that the distance under the two ref-
erences is higher for the Cell Ranger estimates than for the
alevin estimates. Due to the increased homology among
genes between the references, the ratio of reads mapping
to multiple genes increases, resulting in more information
being discarded by Cell Ranger. The total number of UMIs
accounted for by Cell Ranger decreases by ∼ 20, 000, in
comparison, the number of distinct UMIs predicted by
alevin decreased by ∼ 1500, which one might attribute
to changes in the underlying PUGs as a result of map-
ping ∼ 0.01% more reads. The number of human genes
expressed (non-zero UMI count) under the joint refer-
ence is 624 for Cell Ranger and 600 for alevin, out of a
total of 58,288 genes. Note that in both cases, these genes
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Fig. 4 a The Spearman correlation between quantification estimates (summed across all cells) from different scRNA-seq methods against bulk data
from the mouse neuronal and human PBMC datasets, stratified by gene sequence uniqueness. The bar plot on the top of each figure shows the
percentage of genes in each bin that have unique read evidence. Tier 1 is the set of genes with only uniquely mapping reads. Tier 2 is genes that
have ambiguously mapping reads, but are connected to unique read evidence that can be used to resolve the multimapping reads. Tier 3 is genes
that are completely ambiguous. Note that all methods perform very similarly on genes from tier 1, but the performance of alevin is much better for
the other tiers. b Comparison of various methods used to process Drop-seq data from mouse retina with 4k cells. The Spearman correlation is
calculated against bulk quantification estimates predicted using Bowtie2 and RSEM on data from the same cell type
account for < 0.05% of the total UMI count predicted by
each method.
To provide a statistical analysis of the differences
observed for the methods under the two different ref-
erence sequences, we performed the following test. We
sample, randomly, 1000 sets of 100 cells from the entire
experiment, and for each sample, we compute the sum of
Table 5 Number of genes in each bin, when stratified by gene
uniqueness
Bin number Human Mouse
1 3155 4786
2 894 1089
3 853 945
4 822 1061
5 962 1104
6 1174 1318
7 1565 1476
8 2546 1877
9 4695 2960
10 41622 36763
absolute difference between the predictions of each tool
under both references. We compare the resulting distri-
bution of differences for Cell Ranger with that of alevin
and find that the differences in alevin’s quantifications are
smaller than those of Cell Ranger (p < 0.001, Mann-
Whitney-Wilcoxon test). These distributions are plotted
in Additional file 1: Figure S3.
We also show in Fig. 7b that, for the genes that have
sequence similarity in the joint reference but are unique in
the mouse genome, Cell Ranger expression estimates vary
much more than those from alevin.
Time andmemory efficiency
The time and memory requirements for alevin are signif-
icantly less than those for the existing pipelines (Fig. 8),
where all methods were run using 16 threads. DropEst is
excluded from the figure since it consumes the BAM file
output by Cell Ranger and is not a complete end-to-end
pipeline. For the smallest dataset (900 mouse neuronal
cells), alevin was ∼ 5 times faster than naïve and ∼ 21
times faster than Cell Ranger. This difference increases
further as the size of the dataset increases, since the per-
formance of alevin scales better than the other tools.
Hence, where alevin took only 70 min to process the
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Fig. 5 Expression of the Hba and Hbb genes as predicted by alevin and Cell Ranger in mouse neuronal cells. The title of each plot is the name of the
gene and its k-mer uniqueness ratio. Note that Cell Ranger systematically under-estimates the expression of these genes compared to alevin. This
bias is greater for the Hba genes, which have a lower uniqueness ratio, and therefore, a greater number of multimapping reads
human PBMC 8k dataset, Cell Ranger took 22 h and naïve
took 11 h. On this dataset, dropEst took ∼ 2 hours, after
Cell Ranger was used to process and align the reads. In
terms of memory, alevin used only ∼13 GB on the human
PBMC 8k cell dataset, whereas naïve took ∼ 20 GB and
dropEst took ∼ 32 GB. For the mouse neuronal 9k cell
dataset, alevin used ∼14 GB, naïve ∼18 GB, and dropEst
∼ 52 GB. In both cases, Cell Ranger required a minimum
of 16 GB just for STAR indexing.We note that Cell Ranger
allows the user to specify a maximum resident memory
limit, and we ran Cell Ranger allowing it to allocate up to
120 GB so that the extra runtime was not due to limita-
tions in available memory. We also note that for dropEst,
we were not able to run the Bayesian collision correction
algorithm implemented in dropEstr; however, given the
Fig. 6 Expression of the YIPF6 gene (which has a high uniqueness
ratio) as predicted by alevin and Cell Ranger in the PBMC8k data
relatively long UMI tags employed in chromiumV2 chem-
istry compared to inDrop, one would expect the effect of
this extra phase to be limited anyway.
We observe that the optimal number of threads for run-
ning alevin is 10–12, where the maximum gain in terms
of time and memory is achieved. Alevin is designed to
make efficient use of multiple threads, though the opti-
mal number of threads can depend on many factors, such
as the speed of the underlying disk and the size of the
raw input and output matrix to be written. While runtime
decreases with the number of threads used, the memory
profile changes very little as threads are added.
Comparison on Drop-seq data
In addition to the data generated using the 10X
Chromium protocol [3], we also tested alevin on mouse
retina data generated using the Drop-seq protocol [1].
We compare alevin against UMI-tools (the naïve pipeline
from the main paper), dropEst, and dropseq_utils [1]—
the processing pipeline originally used by Macosko et al.
[1]. Again, we compared the correlation of gene abun-
dances, summed across all cells and as produced by the
different methods with the estimates from bulk data [22]
in the same tissue (Fig. 4b). We observe a similar trend
across gene-uniqueness bins as was observed for the 10x
datasets. Alevin demonstrates higher correlation, overall,
with the bulk data, and the improvements are particularly
substantial for genes that are not sequence-unique. Fur-
ther, alevin is much faster and takes less memory than the
other pipelines. Alevin took 17 min to process this data,
which is much faster than the UMI-tools-based pipeline
(∼3.2 h), the dropseq_utils-based pipeline (∼15.5 h), and
even dropEst (25 min). The memory usage of alevin was
6.5 GB, which is less than half the memory usage of the
closest tool (UMI-tools at 17.72 GB). The dropseq_utils-
based pipeline took 25.07 GB while dropEst used 10.8 GB,
which does not include the memory consumed by Cell
Ranger to index the reference and align reads against
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Fig. 7 a Histogram of the 1 distance between the quantification estimates of tools on the mouse neuron 900 data, when run using different
references for quantification (just mouse versus mouse and human). Results are presented for both alevin and Cell Ranger. Since, in reality, all reads
are expected to originate from mouse, deviations from quantifications under the only mouse reference signify misestimation—often due to the
introduction of sequence-similar genes in the human genome. Alevin is able to resolve this ambiguity well, while Cell Ranger instead discards such
reads, leading to different quantification estimates under the two references. b Counts for the topmost genes that have high sequence homology
between human and mouse but are sequence unique in the mouse reference. The title of each plot is the gene name along with the sequence
uniqueness ratio under just the mouse reference and under the joint reference. Hence, the Cell Ranger counts decrease across cells when the gene
uniqueness decreases. Note that these genes were filtered such that they have > 100 count difference for either alevin or Cell Ranger when
summed across all cells
it to produce the BAM file. While alevin has been pri-
marily designed and tested with 10x data in mind, the
method is generic for droplet-based tagged-end proto-
cols, and we observe that it also seems to perform well on
Drop-seq data.
Conclusion
We present a new end-to-end pipeline for performing
gene-level quantification from dscRNA-seq that is accu-
rate, efficient, and easy to use. Our method, alevin, relies
on a new formulation of the UMI resolution problem
Fig. 8 The time and memory performance of the different pipelines on the five datasets. Alevin requires significantly less time and memory than the
other pipelines. Note that for Cell Ranger, the memory plotted is the lower bound, which is the size of the index and the actual memory usage can
be much higher
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that both accounts for transcript-level constraints on how
UMIs may have been generated and that allows resolving
the potential origin of a UMI even when the correspond-
ing reads map between multiple genes.
Our analyses demonstrate that, compared to Cell
Ranger (and naïve), alevin achieves a higher accuracy, in
part because of considering a substantially larger num-
ber of reads. Further, alevin is considerably faster and uses
less memory than these other approaches. These speed
improvements are due to a combination of the fact that
alevin uses bespoke algorithms for CB and UMI edit dis-
tance computation, read mapping, and other tasks and is
a unified tool for performing all of the initial processing
steps, obviating the need to read and write large interme-
diate files on disk. These optimizations make it possible
to efficiently process dscRNA-seq datasets on commodity
computers reducing computational barriers to processing
and re-processing of such data.
In the future, we hope to further improve the bench-
marking of accuracy for single-cell quantification and
barcode whitelisting approaches, as the lack of stan-
dard benchmarks makes the assessment of new meth-
ods difficult. We also hope to explore alternative cell
barcode whitelisting and PUG resolution strategies—
for example, adopting a generative model for PCR and
sequencing error and seeking a maximum likelihood
rather than maximum parsimony-based resolution of
the PUGs.
Alevin is written in C++14 and is integrated into the
salmon tool available at https://github.com/COMBINE-
lab/salmon.
Materials andmethods
Initial whitelisting and barcode correction
After standard quality control procedures, the first step of
existing single-cell RNA-seq processing pipelines [1–3] is
to extract cell barcode and UMI sequences and to add this
information to the header of the sequenced read or save it
in temporary files. This approach, while versatile, can cre-
ate many intermediate files on disk for further processing,
which can be time- and space-consuming.
Alevin begins with sample-demultiplexed FASTQ files.
It quickly iterates over the file containing the barcode
reads and tallies the frequency of all observed barcodes
(regardless of putative errors). We denote the collection
of all observed barcodes as B. Whitelisting involves deter-
mining which of these barcodes may have derived from a
valid cell. When the data has been previously processed
by another pipeline, a whitelist may already be available
for alevin to use. When a whitelist is not available, alevin
uses a two-step procedure for calculating one. An initial
draft whitelist is produced using the procedure explained
below, to select CBs for initial quantification. This list
is refined after per-cell-level quantification estimates are
available (see “Final whitelisting (optional)” section) to
produce a final whitelist.
To generate a putative whitelist, we follow the approach
taken by other dscRNA-seq pipelines by analyzing the
cumulative distribution of barcode frequencies and find-
ing the knee in this curve [1, 2]. Those barcodes occurring
after the knee constitute the whitelist, denoted W . We
use a Gaussian kernel to estimate the probability density
function for the barcode frequency and select the local
minimum corresponding to the “knee.” In the case of a
user-provided whitelist, the provided W is used as the
fixed final whitelist.
Next, we consider those barcodes in E = B \ W to
determine, for each non-whitelisted barcode, whether (a)
its corresponding reads should be assigned to some bar-
code inW or (b) this barcode represents some other type
of noise or error (e.g., ambient RNA, lysed cell) and its
associated reads should be discarded. The approach of
alevin is to determine, for each barcode hj ∈ E , the set
of whitelisted barcodes with which hj could be associ-
ated. We call these the putative labels of hj—denoted as
(hj). Following the criteria used by previous pipelines
[1], we consider a whitelisted barcode wi to be a putative
label for some erroneous barcode hj if hj can be obtained
from wi by a substitution, by a single insertion (and clip-
ping of the terminal base) or by a single deletion (and the
addition of a valid nucleotide to the end of hj). Rather
than applying traditional algorithms for computing the
all-versus-all edit-distances directly, and then filtering for
such occurrences, we exploit the fact that barcodes are rel-
atively short. Therefore, we can explicitly iterate over all of
the valid wi ∈ W and enumerate all erroneous barcodes
for which this might be a putative label. Let Q(wi,H) be
the set of barcodes from E that adhere to the conditions
defined above; then, for each hj ∈ Q(wi,H), we append wi
as putative label for the erroneous barcode hj.
Once all whitelisted barcodes have been processed, each
element in E will have zero or more putative labels. If
an erroneous barcode has more than one putative label,
we prioritize substitutions over insertions and deletions.
If this does not yield a single label, ties are broken
randomly. If no candidate is discovered for an erro-
neous barcode, then this barcode is considered “noise,”
and its associated reads are simply discarded. Note that,
although adopted from existing methods, the alevin ini-
tial whitelisting process is designed to output a larger
number of CBs.
Mapping reads and UMI deduplication
After labeling each barcode, either as noise or as belonging
to some whitelisted barcode, alevin maps the sequenced
reads to the target transcriptome [10, 11]. Reads map-
ping to a given transcript (or multimapping to a set of
transcripts) are categorized hierarchically, first based on
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the label of their corresponding cellular barcode, and then
based on their unique molecular identifier (UMI). At this
point, it is then possible to deduplicate reads based on
their mapping and UMI information.
The process of read deduplication involves the iden-
tification of duplicate reads based on their UMIs and
alignment positions. Most amplification occurs prior to
fragmentation in library construction for 10X Chromium
protocols [23]. Because of this, the alignment position of a
given read is not straightforward to interpret with respect
to deduplication, as the same initial unique molecule may
yield reads with different alignment coordinates2. UMIs
can also contain sequence errors. Thus, achieving the cor-
rect deduplication requires proper consideration of the
available positional information and possible errors.
Our approach for handling sequencing errors and PCR
errors in the UMIs is motivated by “directional” approach
introduced in UMI-tools [5]. Let Ui be the set of UMIs
observed for gene i. A specific UMI un ∈ Ui, observed
cn times in gene i, is considered to have arisen by PCR
or sequence error if there exists um ∈ Ui such that
d(un,um) = 1 and cm > 2cn + 1, where d(·, ·) is the Ham-
ming distance. Using this information, only UMIs that
could not have arisen as an error under this model are
retained. However, this approach may over-collapse UMIs
if there exists evidence that similar UMIs (i.e., UMIs at
a Hamming distance of 1 or less) may have arisen from
different transcripts and, hence, distinct molecules. More-
over, this approach first discards reads that multimap
to more than one read, causing it to lose a substantial
amount of information before even beginning the UMI
deduplication process.
As previously proposed to address the problem of
cell clustering [24], an equivalence class [12, 13, 25–29]
encodes some positional information, by means of encod-
ing the set of transcripts to which a fragment is mapped.
Specifically, these equivalence classes can encode con-
straints about which UMIs may have arisen from the
same molecule and which UMIs—even if mapping to the
same gene—must have derived from distinct pre-PCR
molecules. This can be used to avoid over-collapsing UMI
tags that are likely to result from different molecules by
considering UMIs as distinct for each equivalence class.
However, in its simplest form, this deduplication method
is prone to reporting a considerably higher number of dis-
tinct UMIs than likely exist. This is because reads from
different positions along a single transcript, and tagged
with the same UMI, can give rise to different equiva-
lence classes, so that membership in a different equiva-
lence class is not, alone, sufficient evidence that a read
must have derived from a distinct (pre-PCR) molecule.
This deters us from directly using such a UMI-collapsing
strategy for deriving gene-level counts, though it may be
helpful for other types of analyses.
Given the shortcomings of both approaches to UMI
deduplication, we propose, instead, a novel UMI reso-
lution algorithm that takes into account transcript-level
evidence when it exists, while simultaneously avoiding the
problem of under-collapsing that can occur if equivalence
classes are treated independently for the purposes of UMI
deduplication.
UMI resolution algorithm
A potential drawback of the gene-level deduplication is
that it discards transcript-level evidence. In this case,
such evidence is encoded in the equivalence classes.
Thus, gene-level deduplication provides a conservative
approach and assumes that it is highly unlikely for
molecules that are distinct transcripts of the same gene
to be tagged with a similar UMI (within an edit distance
of 1 from another UMI from the same gene). However,
entirely discarding transcript-level information will mask
true UMI collisions to some degree, even when there is
direct evidence that similar UMIs must have arisen from
distinct transcripts. For example, if similar UMIs appear
in transcript-disjoint equivalence classes (even if all of
the transcripts labeling both classes belong to the same
gene), then they cannot have arisen from the same pre-
PCRmolecule. Accounting for such cases is especially true
when using an error-aware deduplication approach and as
sequencing depth increases.
To perform UMI deduplication, alevin begins by con-
structing a parsimonious UMI graph (PUG), G = (V ,E),
for each cell, where each vi = (u,Ti) is a tuple consist-
ing of UMI sequence u and a set of transcripts Ti =
{ti1 , ti2 , . . . , tim}. There is a count associated with each ver-
tex such that c(vi) = ci is the number of times this UMI
equivalence class pair is observed. G contains two types
of edges: directed and bi-directed. There exists a directed
edge between every pair of vertices (vi, vj) for which ci >
2cj − 1,
∣
∣Ti ∩ Tj
∣
∣ > 0, and d(umi(vi), umi(vj)) = 1. For
every pair of vertices for which there is no directed edge,
there exists a bi-directed edge if d(umi(vk), umi(v)) ≤ 1,
and |Tk ∩ T| > 0. Once the edges of this PUG have been
formed, we no longer need to consider the counts of the
individual UMI equivalence class pairs.
Before proceeding further, we introduce the notion of
monochromatic arborescences in terms of this graph G.
We can refer to the transcript labels of each node as the
potential colors of the node. Since our graph is directed,
an arborescence would be a rooted tree in the graph,
where each node within the arborescence has exactly one
directed path reaching it from a determined root node,
using edges in the arborescence. Given these definitions,
a monochromatic arborescence is one where the set of
colors of the nodes within the arborescence have a non-
null intersection and, hence, the arborescence can be
labeled using a single color. Then, for a given connected
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component in the graph, we can find different sets of
monochromatic arborescences and, for our graph, each
one represents a single pre-PCR molecule.
However, motivated by the principle of parsimony, we
wish to explain the observed vertices (i.e., UMI, equiv-
alence class pairs) via the minimum possible number of
pre-PCR molecules that are consistent with the observed
data. Hence, we pose this problem in the following man-
ner. Given a graph G, we seek a minimum cardinal-
ity covering by monochromatic arborescences. In other
words, we wish to cover G by a collection of vertex-
disjoint arborescences, where each arborescence is labeled
consistently by a set of transcripts, which are the pre-
PCR molecule types from which its reads and UMIs
are posited to have arisen. Further, we wish to cover all
vertices in G using the minimum possible number of
arborescences. Here, the graph G defines which UMI,
read pairs can potentially be explained in terms of oth-
ers (i.e., which vertices may have arisen from the same
molecule by virtue of different fragmentation positions
or which vertices may have given rise to other through
PCR duplication with error). The decision version of
this problem is NP-complete, as shown below and so,
alevin employs a greedy algorithm in practice to obtain
a valid, though not necessarily minimum, covering of
G. We note that while numerous covering and packing
problems related to arborescences have appeared in the
literature (Bernáth and Pap [30] and references therein),
to the best of our knowledge, the following problem
formulation is new.
Theorem 1 Minimum cardinality covering by
monochromatic arborescences is NP-complete.
Proof Consider a reduction from dominating set. Let
(G, k) be an instance of the dominating set problem where
G = (V ,E) is an undirected graph. Then, we can construct
a new graphG′ = (V ,E′) such thatG′ has a minimum car-
dinality covering by ≤ k monochromatic arborescences if
and only if G has a minimum dominating set of size ≤ k.
The color of an arborescence is chosen from among the
intersection of the set of labels for each node it covers and,
hence, is non-null. Construct G′ as follows. Convert each
edge in G to a bi-directed edge in G′ and label each node
with the union of its own label and the labels of all nodes
to which it is directly connected in G. In other words,
Ti = {i} ∪ {j | {i, j} ∈ E}.
→ If G has a minimum dominating set of size k, then G′
has a minimum cardinality covering by k monochromatic
arborescences. Every node in the original graph G has to
be connected to at least one node in the dominating set.
Due to the manner in which node labels are assigned in
G′, this means that every node in G′ can be covered by
an arborescence starting from a dominating set node; this
arborescence is colored by the label assigned to that node.
Since there are k nodes in the dominating set, there will
be k monochromatic arborescences in G′, and since the k
nodes inG dominateV, the arborescences will cover all ofV.
← If G′ has a covering of k monochromatic arbores-
cences, then G has a dominating set of size k. An arbores-
cence is assigned a color, let us say i, from the intersection
of the labels of the nodes it covers. Hence, the node with
label i in G′ has to be one of the nodes covered by
this arborescence. That node connects to all the nodes in
this arborescence; otherwise, they would not have shared
this label. Let these nodes be selected as the dominat-
ing set of G. Hence, if there are k arborescences, there
are k such nodes that are part of the dominating set, and
because the arborescences cover all of G′, the selected
nodes, likewise, dominate G.
The algorithm employed by alevin works as follows.
First, we note that weakly connected components of G
can be processed independently, and so, we describe
here the procedure used to resolve UMIs within a sin-
gle weakly connected component—this is repeated for all
such components. Let C = (VC ,EC) denote our current
component. We perform a breadth-first search starting
from each vertex vi ∈ VC and considering each tran-
script tij (the jth transcript in the equivalence class label-
ing vertex vi). We compute the size (cardinality) of the
largest arborescence that can be created starting from
this node and using this label to cover the visited ver-
tices. Let vi′ , ti′j′ be the vertex, transcript pair generating
the largest arborescence, and let a
(
vi′ , ti′j′
)
be the corre-
sponding arborescence. We now remove all of the vertices
in a
(
vi′ , ti′j′
)
, and all of their incident edges, from C, and
we repeat the same procedure on the remaining graph.
This process is iterated until all vertices of C have been
removed. This procedure is guaranteed to select some
positive order arborescence (i.e., an arborescence con-
taining at least one node) in each iteration and hence is
guaranteed to terminate after at most a linear number of
iterations in the order of C.
After computing a covering, each arborescence is
labeled with a particular transcript. However, the selected
transcript may not be the unique transcript capable of
producing this particular arborescence starting from the
chosen root node. We can compute, for each arbores-
cence, the set of possible transcript labels that could have
colored it (i.e., those in the intersection of the equivalence
class labels for all of the vertices in the arborescence). If
the cardinality of this set is 1, then only a single tran-
script is capable of explaining all of the UMIs associated
with this arborescence. If the cardinality of this set is > 1,
then we need to determine if all transcripts capable of
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covering this arborescence belong to the same gene, or
whether transcripts from multiple genes may, in fact, be
capable of explaining the associated UMIs. In the former
case, the count of pre-PCR molecules (i.e., distinct, dedu-
plicated UMIs) associated with this uniquely selected gene
is incremented by 1. In the latter case, the molecule asso-
ciated with the arborescence is considered to potentially
arise from any of the genes with which it could be labeled.
Subsequently, an EM algorithm is used to distribute the
counts between the genes. Note that other pipelines sim-
ply discard these gene-ambiguous reads and that both
manners in which alevin attempts to resolve such reads
(i.e., either by being selected via the parsimony condition
or probabilistically allocated by the EM algorithm) are
novel in the context of scRNA-seq quantification. The EM
procedure we adopt to resolve ambiguous arborescences
proceeds in the same manner as the EM algorithm used
for transcript estimation in bulk RNA-seq data [13], with
the exception that we assume the probability of generating
a fragment is directly proportional to the estimated abun-
dance, rather than the abundance divided by the effective
length (i.e., we assume that, in the tagged-end protocols
used, there is no length effect in the fragment generation
process).
Tier assignment
The alevin program also outputs a tier matrix, of the
same dimensions as the cell gene count matrix. Within a
cell, each gene is assigned one of four tiers. The first tier
(assigned 0) is the set of genes that have no read evidence
in this cell and are, therefore, predicted to be unexpressed
(whether truly absent, or the effect of some dropout pro-
cess). The rest of the tiers (1, 2, and 3) are assigned based
on a graph induced by the transcript equivalence classes
as follows:
1 All equivalence classes of size 1 are filtered out. The
genes associated with the transcripts from these
classes are assigned to tier 1.
2 For the remaining equivalence classes, of size > 1
gene, a graph G is constructed. The nodes in G are
transcripts, and two nodes share an edge if their
corresponding transcripts belong to a single
equivalence class.
3 All the connected components in G are listed, and
the transcript labels on the nodes mapped to their
corresponding genes. If any component contains a
node whose gene has previously been assigned to tier
1, that gene and all other genes in this connected
component are assigned to tier 2. Hence, tier 2
contains genes whose quantification is impacted by
the EM algorithm (after the UMI deduplication).
4 Genes associated with the remaining nodes in the
graph are assigned to tier 3. These are genes that
have no unique evidence and do not share reads (or,
in fact, paths in the equivalence class graph) with
another gene that has unique evidence. Hence, the
EM algorithm will distribute reads between these
genes in an essentially uniform manner, and their
estimates are uninformative. Their abundance
signifies that some genes (at least 1) in this ambiguous
family are expressed, but exactly which and their
distribution of abundances cannot be determined.
Alevin, optionally (using the --numCellBootstraps
flag), also outputs bootstrap variance estimates for genes
within each cell. These variance estimates could con-
ceivably be used by downstream tools for dimensionality
reduction, differential expression testing, or other tasks.
Final whitelisting (optional)
Many existing tools for whitelisting CBs, such as Cell
Ranger [3] and Sircel [7] perform whitelisting only once.
As discussed above, both tools rely on the assumption
that the number of times a CB is observed is suffi-
cient to identify the correct CBs, i.e., those originating
from droplets containing a cell. However, as observed
by Petukhov et al. [8], there is considerable variation in
sequencing depth per cell, and some droplets may con-
tain damaged or low-quality cells. Thus, true CBs may
fall below a simple knee-like threshold. Similarly, erro-
neous CBs may lie above the threshold. Petukhov et al. [8]
proposed that instead of selecting a single threshold, one
should treat whitelisting as a classification problem and
segregate CBs into three regions: high quality, low qual-
ity, and uncertain/ambiguous. Here, high quality refers to
the CBs which are deemed to be definitely correct, and
low quality are the CBs which are deemed to most likely
not arise from valid cells. A classifier can then be trained
on the high- and low-quality CBs to classify the barcodes
in the ambiguous region as either high or low quality. We
adopt this approach in alevin, using our knee method’s
cutoff to determine the ambiguous region. Specifically, we
divide everything above the knee threshold into two equal
regions: high-quality valid barcodes (upper-half ), denoted
by H, and ambiguous barcodes (lower-half ), denoted by
L. Since the initial whitelisting procedure is very liberal
in selecting a threshold, most of the recoverable, low-
confidence CBs tend to reside in the ambiguous region,
and to learn the low-quality region, we take nl = max(0.2 ·
|H| , 1000) barcodes just below the knee threshold.
In the implementation of Petukhov et al.[8], a kernel
density estimation classifier was trained using features
which described the number of reads per UMI, UMIs per
gene, the fraction of intergenic reads, non-aligned reads,
the fraction of lowly expressed genes, and the fraction
of UMIs on lowly expressed genes. In addition, a maxi-
mum allowable mitochondrial read content was set for a
CB to be classified as “high-quality.” Whilst these features
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enabled the authors to build a classifier which efficiently
separated “high-quality” cells from “low-quality” cells, we
believe it may be possible to improve this set of features.
Specifically, most of these features would be expected to
correlate with the number of reads or UMIs per CB. Thus,
the classifier is biased towards attributes associated with
higher read depth, when in fact one wants it to learn the
feature attributes associated with high-quality cells. We
therefore used a slightly different set of features, listed
below, which we believemay better capture the differences
between high- and low-quality cells. While these features
work in general, they may not be suitable for all analy-
ses and will have to be tweaked accordingly. We chose
to use a naïve Bayes classifier to perform classification,
since we observed no clear difference between multiple
ML methods (not shown), and the naïve Bayes classifier
yields classification probabilities which are easy to inter-
pret. Our final set of whitelisted CBs are those classified
as high confidence.
1 Fraction of reads mapped
2 Fraction of mitochondrial reads (optionally activated
by --mRNA flag)
3 Fraction of rRNA reads (optionally activated by
--rRNA flag)
4 Duplication rate
5 Mean gene counts post deduplication
6 The maximum correlation of gene-level
quantification estimates with the high-quality CBs
(optionally activated by -useCorrelation flag)
Machine configuration and pipeline replicability
10x v2 chemistry benchmarking has been scripted
using CGATCore (https://github.com/cgat-developers/
cgat-core). The full pipeline and analysis are performed
using Stony Brook’s seawulf cluster with 164 Intel Xeon
E5–2683v3 CPUs.
For all analyses, the genome and gtf versions used
for human datasets were GENCODE release 27,
GRCh38.p10, and for mouse datasets were GENCODE
release M16, GRCm38.p5. All transcriptome files were
generated using these with “rsem-prepare-reference.”
Cell Ranger (v2.2.0): The following additional flags were
used, as recommended by the Cell Ranger guidelines:
--nosecondary --expect-cells NumCells,
where NumCells is 10,000 for PBMC 8k and Neurons
9k, 5,000 for PBMC 4k, and 2,000 for Neurons 2k and
Neurons 900.
Alevin (v0.13.0): Run with default parameters with the
Chromium protocol and --keepDuplicates flags and
the -lISR to specify strandedness. ThemRNA and rRNA
lists were obtained from the relevant annotation files
and passed as input. Experiments on v1 chemistry can
be run using the same flags but with the --gemcode
protocol flag. Alevin also supports 10x v3 chemistry via
the command-line flag --chromiumV3.
STAR (v2.6.0a): The following flag was used, as
recommended by the guidelines of UMI-tools:
--outFilterMultimapNmax 1
featureCounts (v1.6.3): This was run to obtain an output
BAM file and with stranded input (-s 1).
UMI-tools (v0.5.4): The extract command was used
to get the CBs/UMIs, when provided with an external
CB whitelist and attach it to the corresponding reads.
The following flags were used in the count command to
obtain the per-cell gene count matrix: --gene-tag=XT
--wide-format-cell-counts
DropEst (v0.8.5): This was run with the default param-
eters on the 10x BAM files, and the predicted cell counts
from Cell Ranger were used as input.
Dropseq utils (v2.0.0): All the commands were run as
recommended by the authors in the tool’s manual.
The bulk datasets were quantified using Bowtie2 and
RSEM, run as follows:
Bowtie2 (v2.3.4.3): The following flags were used, as rec-
ommended in the guidelines of RSEM: --sensitive
--dpad 0 --gbar 99999999 --mp 1,1 --np 1
--score-min L,0,-0.1 --no-mixed
--no-discordant
RSEM (v1.3.1): Run with default parameters.
Endnotes
1Note that we were not able to run the dropEstr
Bayesian correction method and the results presented are
after running just the dropEst pipeline [31].
2We note that whether the majority of amplification
occurs pre- or post-fragmentation can be protocol spe-
cific and can suggest different strategies for UMI dedu-
plication. Here, we are primarily concerned with the 10X
Chromium protocols, dominated by pre-fragmentation
amplification. However, the method we propose for UMI
deduplication can be applied to other protocols as well.
Additional file
Additional file 1: Supplementary material for alevin efficiently estimates
accurate gene abundances from dscRNA-seq data. Includes
supplementary figures. (PDF 669 kb)
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